Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Accounts Payable
The a/p for Labcorp Holdings Inc. (LH) is $840.80 Million with a year-over-year change of -4.00%. Accounts Payable (A/P) represents money the company owes to suppliers and vendors for goods and services received but not yet paid for.
LH A/P Chart
LH A/P
$840.80M+623.58% 20Y
Zoom
Current A/P
$840.80M
$840.80 Million
Year-over-Year Change
-4.00%
vs. $875.80M prior year
Historical Data
30
Years of data available
Annual A/P History
| Year | A/P | YoY Change | % Change |
|---|---|---|---|
| 2025 | $840.80M | $-35.00M | -4.00% |
| 2024 | $875.80M | +$48.30M | +5.84% |
| 2023 | $827.50M | $-24.70M | -2.90% |
| 2022 | $852.20M | +$230.90M | +37.16% |
| 2021 | $621.30M | $-17.60M | -2.75% |
| 2020 | $638.90M | +$6.60M | +1.04% |
| 2019 | $632.30M | $-2.30M | -0.36% |
| 2018 | $634.60M | +$60.70M | +10.58% |
| 2017 | $573.90M | +$65.50M | +12.88% |
| 2016 | $508.40M | +$11.00M | +2.21% |
| 2015 | $497.40M | +$215.10M | +76.20% |
| 2014 | $282.30M | $-22.20M | -7.29% |
| 2013 | $304.50M | +$67.60M | +28.54% |
| 2012 | $236.90M | $-20.90M | -8.11% |
| 2011 | $257.80M | +$0 | 0.00% |
| 2010 | $257.80M | +$74.70M | +40.80% |
| 2009 | $183.10M | +$23.40M | +14.65% |
| 2008 | $159.70M | +$25.50M | +19.00% |
| 2007 | $134.20M | +$700,000 | +0.52% |
| 2006 | $133.50M | +$17.30M | +14.89% |
| 2005 | $116.20M | +$30.90M | +36.23% |
| 2004 | $85.30M | +$12.30M | +16.85% |
| 2003 | $73.00M | $-6.90M | -8.64% |
| 2002 | $79.90M | +$19.70M | +32.72% |
| 2001 | $60.20M | +$7.40M | +14.02% |
| 2000 | $52.80M | +$9.20M | +21.10% |
| 1999 | $43.60M | $-6.60M | -13.15% |
| 1998 | $50.20M | $-5.70M | -10.20% |
| 1997 | $55.90M | $-9.80M | -14.92% |
| 1996 | $65.70M | — | — |
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter